Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Open accessThe DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers in western countries, with a median survival of 6 months and an extremely low percentage of long-term surviving patients. KRAS mutations are known to be a driver event of PDAC, but targeting mutant KRAS has proved challenging. Targeting oncogene-driven signalling pathways is a clinically validated approach for several devastating diseases. Still, despite marked tumour shrinkage, the frequency of relapse indicates that a fraction of tumour cells survives shut down of oncogenic signalling. Here we explore the role of mutant KRAS in PDAC maintenance using a recently developed inducible mouse model of mutated Kras (Kras(G12D), herein KRas) in a p53(LoxP/WT) background. We demonstrate that a subpopulation of dormant tumour cells surviving oncogene ablation (surviving cells) and responsible for tumour relapse has features of cancer stem cells and relies on oxidative phosphorylation for survival. Transcriptomic and metabolic analyses of surviving cells reveal prominent expression of genes governing mitochondrial function, autophagy and lysosome activity, as well as a strong reliance on mitochondrial respiration and a decreased dependence on glycolysis for cellular energetics. Accordingly, surviving cells show high sensitivity to oxidative phosphorylation inhibitors, which can inhibit tumour recurrence. Our integrated analyses illuminate a therapeutic strategy of combined targeting of the KRAS pathway and mitochondrial respiration to manage pancreatic cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prior studies have demonstrated that genetic ablation of KRAS expression leads to cell cycle arrest and death in cell lines and potent tumor regressions in animal models of PDAC (5–7).”
From Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer (2024) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with this notion, other complex I inhibitors have shown efficacy as anti-tumor agents (Appleyard et al., 2012; Schockel et al., 2015) and may show selective toxicity against oncogene-ablation resistant cells (Viale et al., 2014) and cancer stem cells (Sancho et al., 2015).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Viale et al., 2014
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A recurrent theme in studies on cancer progression is the increased reliance of cancer cells on OXPHOS in advanced stages of disease.”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [103]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast to the proliferating bulk of a tumor, accumulating evidence suggests that quiescent subpopulations of tumor cells are markedly less glycolytic and exhibit higher dependence on oxidative phosphorylation, as well as elevated expression of mitochondrial respiratory components.”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Viale et al., 2014
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In a mouse pancreatic cancer model, ablating oncogenic Kras from established tumors revealed a fraction of cells that survive and eventually propagate.”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [103]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Autophagy regulates lipid metabolism
Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K., Cuervo, A. M., & Czaja, M. J. (2009) · Nature · doi:10.1038/nature07976 · Cited by 3,975
Self-citationTransmission Electron Microscopy
Williams, D. B., & Carter, C. B. (2009) · Springer eBooks · doi:10.1007/978-0-387-76501-3 · Cited by 3,963
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,339
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
Hermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M., Bruns, C. J., & Heeschen, C. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.06.002 · Cited by 2,897
Updated research nosology for HIV-associated neurocognitive disorders
Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., Clifford, D. B., Cinque, P., Epstein, L. G., Goodkin, K., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000287431.88658.8b · Cited by 2,630
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.058 · Cited by 2,043
Self-citationHematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
Kantarjian, H., Sawyers, C., Hochhaus, A., Guilhot, F., Schiffer, C., Gambacorti-Passerini, C., Niederwieser, D., Resta, D., Capdeville, R., Zoellner, U., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011573 · Cited by 2,019
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., et al. (2013) · Nature · doi:10.1038/nature12040 · Cited by 1,990
Self-citation
Cited by
Items 501–600 of 1,000
Artibani, M., Masuda, K., Hu, Z., Rauher, P. C., Mallett, G., Wietek, N. C., Morotti, M., Chong, K. Y., KaramiNejadRanjbar, M., Zois, C. E., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.147929 · Cited by 49
Cancer stem cells: a target for overcoming therapeutic resistance and relapse
Zhang, S., Yang, R., Ouyang, Y., Shen, Y., Hu, L., & Xu, C. S. (2024) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2023.0333 · Cited by 48
Yuan, T., Fu, X., Hu, R., Zheng, X., Jiang, D., Jing, L., Kuang, X., Guo, Z., Xu, L., Liu, Y., et al. (2024) · Trends in biotechnology · doi:10.1016/j.tibtech.2024.06.007 · Cited by 53
The Metabolic Landscape of Cancer Stem Cells: Insights and Implications for Therapy
Milella, M., Rutigliano, M., Pandolfo, S. D., Aveta, A., Crocetto, F., Ferro, M., d’Amati, A., Ditonno, P., Lucarelli, G. T., & Lasorsa, F. M. (2025) · Cells · doi:10.3390/cells14100717 · Cited by 48
Role of pancreatic stellate cells and periostin in pancreatic cancer progression
Liu, Y., & Du, L. (2015) · Tumor Biology · doi:10.1007/s13277-015-3386-2 · Cited by 43
Bioactive lipids in cancer stem cells
Begicevic, R.-R., Arfuso, F., & Falasca, M. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i9.693 · Cited by 43
Dysregulated lipid metabolism in hepatocellular carcinoma cancer stem cells
Bort, A., Sánchez, B. G., de Miguel, I., Mateos‐Gómez, P. A., & Díaz‐Laviada, I. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05352-3 · Cited by 44
Conflicting metabolic alterations in cancer stem cells and regulation by the stromal niche
Yasuda, T., Ishimoto, T., & Baba, H. (2021) · Regenerative Therapy · doi:10.1016/j.reth.2021.01.005 · Cited by 45
Repurposing metformin for the treatment of gastrointestinal cancer
Júnior, A. D. D. C., Bragagnoli, A. S. C., Costa, F. O., & Carvalheira, J. B. C. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i17.1883 · Cited by 46
Chen, Y., & Gibson, S. B. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166265 · Cited by 40
Deciphering Tumor Niches: Lessons From Solid and Hematological Malignancies
Mancini, S. J. C., Balabanian, K., Corre, I., Gavard, J., Lazennec, G., Bousse‐Kerdilès, M. L., Louache, F., Maguer‐Satta, V., Mazure, N. M., Mechta‐Grigoriou, F., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.766275 · Cited by 46
Phytochemicals Target Multiple Metabolic Pathways in Cancer
Shuvalov, O. Y., Kirdeeva, Y., Daks, A. A., Fedorova, O., Parfenyev, S. E., Simon, H., & Barlev, N. A. (2023) · Antioxidants · doi:10.3390/antiox12112012 · Cited by 51
The role of glycolysis in tumorigenesis: From biological aspects to therapeutic opportunities
Cordani, M., Michetti, F., Zarrabi, A., Zarepour, A., Rumio, C., Strippoli, R., & Marcucci, F. (2024) · Neoplasia · doi:10.1016/j.neo.2024.101076 · Cited by 40
Integrating autophagy and metabolism in cancer
Cheong, H. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0562-2 · Cited by 45
Concise Review: Stem Cells in Pancreatic Cancer: From Concept to Translation
Raj, D., Aicher, A., & Heeschen, C. (2015) · Stem Cells · doi:10.1002/stem.2114 · Cited by 44
Senkowski, W., Jarvius, M., Rubin, J., Lengqvist, J., Gustafsson, M. G., Nygren, P., Kultima, K., Larsson, R. L., & Fryknäs, M. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.09.013 · Cited by 42
Research progress on therapeutic targeting of quiescent cancer cells
Zhang, J., Si, J., Gan, L., Di, C., Xie, Y., Sun, C., Li, H., Guo, M., & Zhang, H. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1638793 · Cited by 45
Peruzzo, R., Costa, R., Bachmann, M., Leanza, L., & Szabó, I. (2020) · Cancers · doi:10.3390/cancers12092574 · Cited by 46
Zhou, Y., Zou, J., Xu, J. B., Zhou, Y., Cen, X., & Zhao, Y. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115219 · Cited by 45
Andersen, H. B., Ialchina, R., Pedersen, S. F., & Czaplińska, D. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10004-4 · Cited by 50
Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma
Liang, C., Qin, Y., Zhang, B., Ji, S., Shi, S., Xu, W., Liu, J., Xiang, J., Liang, D., Hu, Q., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.09.001 · Cited by 40
Stem Cell Metabolism in Cancer and Healthy Tissues: Pyruvate in the Limelight
Corbet, C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00958 · Cited by 43
Mitochondrial metabolism is inhibited by the HIF 1α‐ MYC ‐ PGC ‐1β axis in BRAF V600E thyroid cancer
Gao, Y., Yang, F., Yang, X., Zhang, L., Yu, H., Cheng, X. F., Xu, S., Pan, J., Wang, K., & Li, P. (2019) · FEBS Journal · doi:10.1111/febs.14786 · Cited by 44
Kim, J., & Cheong, J. (2020) · Cells · doi:10.3390/cells9071691 · Cited by 41
Energy sources identify metabolic phenotypes in pancreatic cancer
Liang, C., Qin, Y., Zhang, B., Ji, S., Shi, S., Xu, W., Liu, J., Xiang, J., Liang, D., Hu, Q., et al. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmw097 · Cited by 42
Cancer cells exploit adaptive mitochondrial dynamics to increase tumor cell invasion
Caino, M., & Altieri, D. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1084448 · Cited by 36
BICC1 drives pancreatic cancer stemness and chemoresistance by facilitating tryptophan metabolism
Sun, H., Li, H., Guan, Y., Yuan, Y., Xu, C., Fu, D., Xie, P., Li, J., Zhao, T., Wang, X., et al. (2024) · Science Advances · doi:10.1126/sciadv.adj8650 · Cited by 41
Self-citationGermain, D. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.01.004 · Cited by 38
Role of autophagy in the maintenance and function of cancer stem cells
Vitale, I., Manic, G., Dandrea, V., & Maria, R. D. (2015) · The International Journal of Developmental Biology · doi:10.1387/ijdb.150082iv · Cited by 40
Ippolito, J. E., Brandenburg, M. W., Ge, X., Crowley, J. R., Kirmess, K. M., Som, A., d’Avignon, D. A., Arbeit, J. M., Achilefu, S., Yarasheski, K. E., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159675 · Cited by 40
Metabolic Features of Cancer Treatment Resistance
Viale, A., & Draetta, G. F. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-42118-6_6 · Cited by 39
Self-citationBCL3 exerts an oncogenic function by regulating STAT3 in human cervical cancer
Zhao, H., Wang, W., Zhao, Q., Hu, G., Deng, K., & Liu, Y. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s118184 · Cited by 38
Relationship of Metabolic Alterations and PD-L1 Expression in Cisplatin Resistant Lung Cancer
Wangpaichitr, M., Kandemir, H., Li, Y. Y., Wu, C., Nguyen, D., Feun, L. G., Kuo, M. T., & Savaraj, N. (2017) · Cell & Developmental Biology · doi:10.4172/2168-9296.1000183 · Cited by 46
Drug persistence – From antibiotics to cancer therapies
Kochanowski, K., Morinishi, L., Altschuler, S. J., & Wu, L. F. (2018) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2018.03.003 · Cited by 36
Monitoring autophagy in cancer: From bench to bedside
Long, M., & McWilliams, T. G. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.05.016 · Cited by 30
Mitochondrial ATP-Dependent Proteases—Biological Function and Potential Anti-Cancer Targets
Feng, Y., Nouri, K., & Schimmer, A. D. (2021) · Cancers · doi:10.3390/cancers13092020 · Cited by 37
Targeting Energy Metabolism in Cancer Treatment
Kubik, J., Humeniuk, E., Adamczuk, G., Madej, B., & Korga-Plewko, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105572 · Cited by 41
Deng, J., Pan, T., Lv, C., Cao, L., Li, L., Zhou, X., Li, G., Li, H., Vicencio, J. M., Xu, Y., et al. (2023) · Theranostics · doi:10.7150/thno.84937 · Cited by 41
Self-citationLacritin and other autophagy associated proteins in ocular surface health
Karnati, R., Talla, V., Peterson, K. M., & Laurie, G. W. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.08.015 · Cited by 41
Pinho, A. V., Mawson, A., Gill, A. J., Arshi, M., Warmerdam, M., Giry-Laterrière, M., Eling, N., Lie, T., Kuster, E., Camargo, S. M. R., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11013 · Cited by 40
Cai, M., He, J., Xiong, J., Tay, L. W. R., Wang, Z., Rog, C. J., Wang, J., Xie, Y., Wang, G., Banno, Y., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.355 · Cited by 38
Different Tumor Microenvironments Lead to Different Metabolic Phenotypes
Antonio, M. J., & Le, A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-77736-8_9 · Cited by 38
T lymphocytes against solid malignancies: winning ways to defeat tumours
Caruana, I., Simula, L., Locatelli, F., & Campello, S. (2018) · Cell Stress · doi:10.15698/cst2018.07.148 · Cited by 40
Fabian, A., Stegner, S. H., Miarka, L., Zimmermann, J., Lenk, L., Rahn, S., Buttlar, J., Viol, F., Knaack, H., Esser, D., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.03.039 · Cited by 40
Targeting cancer stem cells from a metabolic perspective
Shen, Y., Pan, S.-C., Chu, I., Lai, R.-Y., & Wei, Y. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220909309 · Cited by 38
Autophagy Contributes to Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Tumors
Reyes‐Castellanos, G., Hadi, N. A., & Carrier, A. (2022) · Cells · doi:10.3390/cells11030426 · Cited by 45
The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib
Zhuo, J., Lu, D., Lin, Z., Yang, X., Yang, M., Wang, J., Tao, Y., Wen, X., Li, H., Lian, Z., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04320-4 · Cited by 39
Cancer-Associated Fibroblast Diversity Shapes Tumor Metabolism in Pancreatic Cancer
Peiffer, R., Boumahd, Y., Gullo, C., Crake, R., Letellier, E., Bellahcène, A., & Peulen, O. (2022) · Cancers · doi:10.3390/cancers15010061 · Cited by 38
Phenformin Enhances the Efficacy of ERK Inhibition in NF1-Mutant Melanoma
Trousil, S., Chen, S., Chan, M., Shaw, F. M., Yao, Z., Ran, Y., Tiwari, S., Merghoub, T., Manstein, D., Rosen, N. X., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.01.013 · Cited by 42
Self-citationSelf-renewal signaling pathways in breast cancer stem cells
Nalla, L. V., Kalia, K., & Khairnar, A. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.12.017 · Cited by 41
Moore, A. M., Zhou, L., Cui, J., Li, L., Wu, N., Yu, A. C., Poddar, S., Liang, K., Abt, E. R., Kim, S., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012469118 · Cited by 42
Redox Control of the Dormant Cancer Cell Life Cycle
Li, B., Huang, Y., Ming, H., Nice, E. C., Xuan, R., & Huang, C. (2021) · Cells · doi:10.3390/cells10102707 · Cited by 39
Starting the engine of the powerhouse: mitochondrial transcription and beyond
Miranda, M., Bonekamp, N. A., & Kühl, I. (2022) · Biological Chemistry · doi:10.1515/hsz-2021-0416 · Cited by 34
The ever-changing landscape of pancreatic cancer stem cells
Sancho, P., Alcalá, S., Usachov, V., Hermann, P. C., & Sáinz, B. (2016) · Pancreatology · doi:10.1016/j.pan.2016.04.004 · Cited by 36
Pereira, S. N., Caiado, F., Carvalho, T., Matias, I., Graça, G., Gonçalves, L. G., Silva‐Santos, B., Norell, H., & Dias, S. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1166 · Cited by 37
Lipid droplets as metabolic determinants for stemness and chemoresistance in cancer
Royo-García, A., Courtois, S., Parejo-Alonso, B., Espiau-Romera, P., & Sancho, P. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i9.1307 · Cited by 36
Targeting redox regulation and autophagy systems in cancer stem cells
Khan, S. U., Rayees, S., Sharma, P., & Malik, F. A. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00955-5 · Cited by 37
Phytochemicals and mitochondria: Therapeutic allies against gastric cancer
Zhao, M., Yang, Y., Nian, Q., Shen, C., Xiao, X., Liao, W., Zheng, Q., Zhang, G., Chen, N., Gong, D., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154608 · Cited by 41
Xiao, C., Li, J., Hua, A., Wang, X., Li, S., Li, Z., Chen, X., Zhang, Z., Yang, X., & Li, Z. (2024) · Research · doi:10.34133/research.0335 · Cited by 48
Fang, B. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv090 · Cited by 41
The Many Facets of Tumor Heterogeneity: Is Metabolism Lagging Behind?
Loponte, S., Lovisa, S., Deem, A. K., Carugo, A., & Viale, A. (2019) · Cancers · doi:10.3390/cancers11101574 · Cited by 39
Self-citationTargeting Mutant KRAS in Pancreatic Cancer: Futile or Promising?
Nollmann, F. I., & Ruess, D. A. (2020) · Biomedicines · doi:10.3390/biomedicines8080281 · Cited by 35
Tuerhong, A., Xu, J., Shi, S., Tan, Z., Meng, Q., Hua, J., Liu, J., Zhang, B., Wang, W., Yu, X., et al. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03866-y · Cited by 39
Homology-directed gene-editing approaches for hematopoietic stem and progenitor cell gene therapy
Azhagiri, M. K. K., Babu, P., Venkatesan, V., & Thangavel, S. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02565-6 · Cited by 35
Active mitochondrial respiration in cancer: a target for the drug
Bedi, M., Ray, M., & Ghosh, A. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04281-4 · Cited by 36
Campioni, G., Pasquale, V., Busti, S., Ducci, G., Sacco, E., & Vanoni, M. (2022) · Cells · doi:10.3390/cells11050866 · Cited by 39
Extracellular Vesicle-Mediated Mitochondrial Reprogramming in Cancer
Carles-Fontana, R., Heaton, N. D., Palma, E., & Khorsandi, S. E. (2022) · Cancers · doi:10.3390/cancers14081865 · Cited by 40
Mitochondrial metabolism: a predictive biomarker of radiotherapy efficacy and toxicity
Taghizadeh‐Hesary, F., Houshyari, M., & Farhadi, M. R. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04592-7 · Cited by 37
Mitochondrial Ca2+ Remodeling is a Prime Factor in Oncogenic Behavior
Rimessi, A., Patergnani, S., Bonora, M., Wieckowski, M. R., & Pinton, P. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00143 · Cited by 38
Therapeutic Strategy for Targeting Aggressive Malignant Gliomas by Disrupting Their Energy Balance
Hegazy, A. M., Yamada, D., Kobayashi, M., Kohno, S., Ueno, M., Ali, M. A., Ohta, K., Tadokoro, Y., Ino, Y., Todo, T., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.734756 · Cited by 36
Wu, J., Li, L., Jiang, G., Zhan, H., & Wang, N. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3729 · Cited by 34
Papkovsky, D. B., & Zhdanov, A. V. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.09.018 · Cited by 34
Lonetto, G., Koifman, G., Silberman, A., Attery, A., Solomon, H., Levin‐Zaidman, S., Goldfinger, N., Porat, Z., Erez, A., & Rotter, V. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0227-z · Cited by 36
Linden, C. V., & Corbet, C. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.016 · Cited by 34
Metabolism remodeling in pancreatic ductal adenocarcinoma
Li, J., Wang, Y.-P., Yin, M., & Lei, Q. (2019) · Cell Stress · doi:10.15698/cst2019.12.205 · Cited by 47
Self-citationMitochondria: A Galaxy in the Hematopoietic and Leukemic Stem Cell Universe
Panuzzo, C., Jovanovski, A., Pergolizzi, B., Pironi, L., Stanga, S., Fava, C., & Cilloni, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113928 · Cited by 37
Kuramoto, K., Yamamoto, M., Suzuki, S., Togashi, K., Sanomachi, T., Kitanaka, C., & Okada, M. (2021) · Genes · doi:10.3390/genes12010099 · Cited by 36
Metabolic resistance to the inhibition of mitochondrial transcription revealed by CRISPR‐Cas9 screen
Mennuni, M., Filograna, R., Felser, A., Bonekamp, N. A., Giavalisco, P., Lytovchenko, O., & Larsson, N. (2021) · EMBO Reports · doi:10.15252/embr.202153054 · Cited by 37
Smith, L. K., Parmenter, T. J., Kleinschmidt, M., Kusnadi, E. P., Kang, J., Martin, C. A., Lau, P. K. H., Patel, R. P., Lorent, J., Papadopoli, D. J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28705-x · Cited by 41
Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review)
Zuzčák, M., & Trnka, J. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5383 · Cited by 39
Oncogenic Addiction of Fibrolamellar Hepatocellular Carcinoma to the Fusion Kinase DNAJB1-PRKACA
Neumayer, C., Ng, D., Jiang, C. S., Qureshi, A., Lalazar, G., VAUGHAN, R. D., & Simon, S. M. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-1851 · Cited by 36
Targeting autophagy and lipid metabolism in cancer stem cells
Chakravarti, B., Siddiqui, J. A., Sinha, R. A., & Raza, S. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115550 · Cited by 40
Zhen, Y., Liu, K., Shi, L., Shah, S., Xu, Q., Ellis, H., Balasooriya, E. R., Kreuzer, J., Morris, R. T., Baldwin, A. S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47514-y · Cited by 41
Therapeutic targeting of lipid synthesis metabolism for selective elimination of cancer stem cells
Kim, W. (2018) · Archives of Pharmacal Research · doi:10.1007/s12272-018-1098-z · Cited by 35
Rademaker, G., Costanza, B., Anania, S., Agirman, F., Maloujahmoum, N., Valentin, E. D., Goval, J.-J., Bellahcène, A., Castronovo, V., & Peulen, O. (2019) · Cancers · doi:10.3390/cancers11060853 · Cited by 38
Wynn, A., Vacheron, A. B., Zuber, J. K., & Solomon, S. S. (2019) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2019.06.002 · Cited by 35
Ren, B., Rose, J. B., Liu, Y., Jaskula‐Sztul, R., Contreras, C. M., Beck, A. W., & Chen, H. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111980 · Cited by 33
Xue, D., Xu, Y., Kyani, A., Roy, J., Dai, L., Sun, D., & Neamati, N. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01934 · Cited by 33
Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics
Marchetti, P., Guerreschi, P., Mortier, L., & Kluza, J. (2015) · International Journal of Cell Biology · doi:10.1155/2015/283145 · Cited by 41
He, P., Feng, J., Xia, X., Sun, Y., He, J., Guan, T., Peng, Y., Zhang, X., Liu, M., Pang, X., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01844 · Cited by 32
Hlavaty, S. I., Salcido, K., Pniewski, K. A., Mukha, D., Ma, W., Kannan, T., Cassel, J. A., Srikanth, Y. V. V., Liu, Q., Kossenkov, A. V., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114988 · Cited by 34
Immune Cell Metabolism in Tumor Microenvironment
Li, Y., Wan, Y. Y., & Zhu, B. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-94-024-1170-6_5 · Cited by 37
Zhou, Y., Xu, Z., Quan, D. L., Zhang, F., Zhang, H., Xiao, T., Hou, S., Qiao, H., Harismendy, O., Wang, J. Y. J., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0349-2 · Cited by 37
Mitochondrial Damage Mediated by miR-1 Overexpression in Cancer Stem Cells
Zhang, S., Liu, C., & Zhang, X. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.05.017 · Cited by 32
Combined nanomedicines targeting colorectal cancer stem cells and cancer cells
Tsakiris, N., Fauvet, F., Selmi‐Ruby, S., Puisieux, A., Paquot, A., Muccioli, G. G., Vigneron, A. M., & Véronique Préat, A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.025 · Cited by 32
Inhibition of ERAD synergizes with FTS to eradicate pancreatic cancer cells
Du, R., Sullivan, D. K., Azizian, N. G., Liu, Y., & Li, Y. (2021) · BMC Cancer · doi:10.1186/s12885-021-07967-6 · Cited by 34
A “Weird” Mitochondrial Fatty Acid Oxidation as a Metabolic “Secret” of Cancer
Zhelev, Z., Aoki, I., Lazarova, D., Vlaykova, T. I., Higashi, T., & Bakalova, R. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2339584 · Cited by 36
A Potential “Anti-Warburg Effect” in Circulating Tumor Cell-mediated Metastatic Progression?
Jiang, Z., He, J., Zhang, B., Wang, L., Long, C., Zhao, B., Yang, Y., Du, L., Luo, W., Hu, J., et al. (2024) · Aging and Disease · doi:10.14336/ad.2023.1227 · Cited by 47
Tabe, Y., & Konopleva, M. Y. (2023) · Cancer Drug Resistance · doi:10.20517/cdr.2022.133 · Cited by 39
Stefano, G. B., & Kream, R. M. (2015) · Medical Science Monitor · doi:10.12659/msm.895990 · Cited by 31
Metadata
- Authors
- Viale, A., Pettazzoni, P., Lyssiotis, C. A., Ying, H., Sánchez, N., Marchesini, M., Carugo, A., Green, T., Seth, S., Giuliani, V., Kost-Alimova, M., Muller, F., Colla, S., Nezi, L., Genovese, G., Deem, A. K., Kapoor, A., Yao, W., Brunetto, E., Kang, Y., Yuan, M., Asara, J. M., Wang, Y. A., Heffernan, T. P., Kimmelman, A. C., Wang, H., Fleming, J. B., Cantley, L. C., DePinho, R. A., & Draetta, G. F.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Weill Cornell Medicine (US)
- IRCCS Ospedale San Raffaele (IT)
- Beth Israel Deaconess Medical Center (US)
- Dana-Farber Cancer Institute (US)
- Corresponding author
- Viale, Andrea
- Draetta, Giulio F.
- ORCID
- Viale, Andrea
- Pettazzoni, Piergiorgio
- Lyssiotis, Costas A.
- Ying, Haoqiang
- Sánchez, Nora
- Marchesini, Matteo
- Carugo, Alessandro
- Seth, Sahil
- Giuliani, Virginia
- Colla, Simona
- Nezi, Luigi
- Genovese, Giannicola
- Deem, Angela K.
- Yao, Wantong
- Brunetto, Emanuela
- Kang, Ya’an
- Yuan, Min
- Asara, John M.
- Wang, Y. Alan
- Heffernan, Timothy P.
- Kimmelman, Alec C.
- Wang, Huamin
- Fleming, Jason B.
- Cantley, Lewis C.
- DePinho, Ronald A.
- Draetta, Giulio F.
- Venue
- Nature
- Published
- 2014-08-10
- Volume
- 514
- Issue
- 7524
- Pages
- 628-632
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4376130
- OpenAlex
- W2023300506
- Semantic Scholar
- 819eeeb41f6e84dd5c00221a269e91238736c4ad
- Cited by
- 1,259
- References
- 125
- Citations by year
- 2026: 93 · 2025: 72 · 2024: 104 · 2023: 105 · 2022: 119 · 2021: 131 · 2020: 135 · 2019: 114 · 2018: 105 · 2017: 90 · 2016: 99 · 2015: 81 · 2014: 8
- FWCI
- 44.61
- Type
- journal article
- Language
- en
- Update notices
- correction (2026-04-08)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (P50CA127003, CA-16672, CA 016672, P01CA120964, P30CA016672, P01CA117969)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- pancreatic ductal adenocarcinoma, KRAS mutation, tumor recurrence, oxidative phosphorylation, mitochondrial respiration, cancer stem cells, autophagy, glycolysis, OXPHOS inhibitors, combination therapy
- MeSH terms
- Animals, Autophagy, Cell Survival, Disease Models, Animal, Female, Glycolysis, Lysosomes, Mitochondria, Mutation, Neoplasm Recurrence, Local, Oxidative Phosphorylation, Pancreatic Neoplasms, Recurrence, Neoplastic Stem Cells, Signal Transduction, Gene Expression Regulation, Neoplastic, Genes, p53, Proto-Oncogene Proteins p21(ras), Cell Respiration, Carcinoma, Pancreatic Ductal, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.